Publications:

 

1. Regulation of cytokine gene transcription:

1.    Baer M, Dillner A, Schwartz RC, Sedon C, Nedospasov SA, Johnston PF. TNF alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kB p50. Mol.Cell.Biol. 1998; 18:5678-5689.
2.    Kaijzel EL, van Krugten MV, Brinkman BM, et al. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998; 4:724-733.
3.    Udalova IA, Knight JC, Vidal V, Nedospasov SA, Kwiatkowski D. Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J.Biol.Chem. 1998; 273: 21178-21186.
4.    Kuprash DV, Udalova IA, Turetskaya RL, Kwiatkowski D, Rice NR, Nedospasov SA. Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J Immunol 1999; 162: 4045-4052.
5.    Kuprash DV, Boitchenko VE, Yarovinsky FO, Rice NR, Nordheim A, Ruhlmann A, Nedospasov SA. Cyclosporin A blocks the expression of lymphotoxin alpha, but not lymphotoxin beta, in human peripheral blood mononuclear cells. Blood. 2002; 100(5): 1721-1727.

 

2. Physiological functions of cytokines:

6.    Endres R, Alimzhanov MB, Plitz T, et al. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med 1999; 189:159-168.
7.    Ito D, Back TC, Shakhov AN, Wiltrout RH, Nedospasov SA. Mice with a Targeted Mutation in Lymphotoxin-alpha Exhibit Enhanced Tumor Growth and Metastasis: Impaired NK Cell Development and Recruitment. J Immunol 1999; 163: 2809-2815.
8.    Kuprash DV, Alimzhanov MB, Tumanov A, Anderson AO, Pfeffer K, Nedospasov SA. TNF and Lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes. J Immunol 1999; 163: 6575-6580.
9.    Drize NI, Drutskaya MS, Gerasimova LP, Manakova TE, Chertkov IL, Turetskaya RL, Kuprash DV, Nedospasov SA. Changes in the hemopoietic system of mice deficient for tumor necrosis factor or lymphotoxin-alpha.
Bull Exp Biol Med [Russian] 2000; 130 (7): 76-79.
1
0.    Shakhov AN, Lyakhov IG, Tumanov AV, et al. Gene profiling approach in the analysis of lymphotoxin and TNF deficiencies. J Leukoc Biol 2000; 68: 151-157.
11.    Shakhov AN, Rubtsov AV, Lyakhov IG, Tumanov A, Nedospasov SA. SPLASH (PLA211D), a novel member of phospholipase A2 family, is associated with lymphotoxin deficiency. Genes Immunity 2000; 1: 191-199.
12.    Drutskaya MS, Kuprash DV, Nedospasov SA, Chertkov IL, Drize NI. Abnormal hemopoiesis in long-term bone marrow culture from tumor necrosis factor-deficient mice.
Bull Exp Biol Med [Russian] 2001 Feb; 131(2): 184-187.
1
3.    Shakhov AN, Nedospasov SA. Expression profiling in knockout mice: lymphotoxin versus tumor necrosis factor in the maintenance of splenic microarchitecture. Cytokine Growth Factor Rev 2001; 12: 107-119.
14.    Hehlgans T, Stoelcker B, Stopfer P, Muller P, Cernaianu G, Guba M, Steinbauer M, Nedospasov SA, Pfeffer K, Mannel DN. Lymphotoxin-beta receptor immune interaction promotes tumor growth by inducing angiogenesis. Cancer Res. 2002 62: 4034-40
15.    Kuprash D.V. Alimzhanov M.B., Tumanov A.V., Ito D., Abe, K., Turetskaya, R.L., Marino, M.W., Anderson A.O., Rajewsky K., Pfeffer K. and Nedospasov S.A. Mutiple deficiencies in immune functions in mice with complete neo-free deletion of the TNF/LT locus (TNF/LTbeta/LTalpha triple-deficient mice). Mol. Cell. Biol., 2002, 22:8626-8634.
16.    Tumanov, A.V., Kuprash, D.V., Lagarkova, M.A., Grivennikov, S.I., Abe, K., Shakhov, A.N., Drutskaya. L.N., Stewart C.L., Chervonsky, A.V. and Nedospasov, S.A. Distinct Role of Surface Lymphotoxin Expressed by B Cells in the Organization of Secondary Lymphoid Tissues. Immunity 2002 17(3): 239-250.
17.    Abe, K., Yarovinsky, F., Murakami, T., Ito, D., Tumanov, A.V., Pfeffer, K., Shakhov, A.N., Kuprash, D.V., Komschlies, K.L., and Nedospasov, S.A. Distinct role of TNF/LT subfamily of cytokines in the development and recruitment of dendritic cells. Blood, 2003, 101:1477-1483.
18.    Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Forster I, Clausen BE, Tessarollo L, Ryffel B, Kuprash DV, Nedospasov SA. Distinct and non-redundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: protective and deleterious effects. Immunity 2005, 22: 93-104.
19.    Liepinsh DJ, Grivennikov SI, Klarmann KD, Lagarkova MA, Drutskaya MS, Lockett SJ, Tessarollo L, McAuliffe M, Keller JR, Kuprash DV, Nedospasov SA. Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: reassessing LTalpha biological functions. Mol Cell Biol 2006, 26:4214-4225.

20. Cui CY, Kunisada M, Esibizione D, Grivennikov SI, Piao Y, Nedospasov SA, Schlessinger D.

Lymphotoxin-{beta} regulates periderm differentiation during embryonic skin development.
Hum Mol Genet. 2007 Aug 1; [Epub ahead of print]

21. Togbe D, Grivennikov SI, Noulin N, Couillin I, Maillet I, Jacobs M, Maret M, Fick L, Nedospasov SA, Quesniaux VF, Schnyder B, Schnyder-Candrian S. T cell-derived TNF down-regulates acute airway response to endotoxin. Eur J Immunol. 2007;37(3):768-79.

 

3. Human cancer antigens and serology:

22.    Lagarkova MA, Boitchenko VE, Mescheryakov AA, Kashkarova UA, Nedospasov SA. Human cortactin as putative cancer antigen. Oncogene 2000; 19: 5204-5207.
23.    Kuimov AN, Kuprash DV, Petrov VN, Vdovichenko KK, Scanlan MJ, Jongeneel CV, Lagarkova MA, Nedospasov SA. Cloning and characterization of TNKL, a member of tankyrase gene family. Genes Immun 2001; 2: 52-55.
24.    Koroleva EP, Lagarkova MA, Mesheryakov AA, Scanlan MJ, Old LJ, Nedospasov SA, Kuprash DV. Serological identification of antigens assosiated with renal cell carcinoma. Russian Journal of Immunology, 2002, 7(3):229-238.
25.    Lagarkova MA, Koroleva EP, Kuprash DV, Boitchenko VE, Kashkarova UA, Nedospasov SA, Shebzukhov YV. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA). Immunology Letters, 2003, 85(1):71-74.
26.    Koroleva EP, Lagarkova MA, Khlgatian SV, Shebzukhov YV, Mescheryakov AA, Lichinitser MR, Nedospasov SA, Kuprash DV. Serologic analysis of repertoire of human cancer antigens and autoantigens. Mol. biologiya [Russian], 2004, 38: 1-6.
27.    Shebzukhov YV, Koroleva  EP, Khlgatian SV, Belousov PV, Kuz’mina KE, Radko BV, Longpre F, Lagarkova MA, Kadachigova TS, Gurova OV, Mescheryakov AA, Lichinitser MR, Knuth A, Jager E, Kuprash DV, and Nedospasov SA. Humoral immune response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients.  Int. J. Cancer 2005a; 117(5):800-806.
28.    Shebzukhov YV, Koroleva EP, Khlgatian SV, Lagarkova MA, Meshcheryakov AA, Lichinitser MR, Karbach J, Jager E, Kuprash DV, Nedospasov SA.   Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy. Immunol Lett. 2005b; 100(1): 88-93.

29. Shebzukhov YV, Koroleva EP, Khlgatian SV, Belousov PV, Sazykin AY, Kadachigova TS, Pomerantseva EA, Lagarkova MA, Nedospasov SA, Kuprash DV. RAP80/UIMC1 as cancer-associated antigen: alternative splice variants and their immunogenicity. Cancer Lett. 2007; 255(2):255-62. Epub 2007 Jun 11.

 

4. Other research in molecular immunology and hematology:

30.    Schroeder HW Jr, Zhu ZB, March RE, Campbell RD, Berney SM, Nedospasov SA, Turetskaya RL, Atkinson TP, Go RC, Cooper MD, Volanakis JE. Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med. 1998, 4:72-86.
31.    Korobko VG, Boichenko VE, Kuprash DV, Turetskaia RL, Nedospasov SA. [Heterologous expression of murine lymphotoxins in Escherichia coli and preparation of antibodies]. Bioorg Khim. 1999 Apr; 25(4):270-274.
32.    Boitchenko VE, Korobko VG, Prasolov VS, Kravchenko VV, Kuimov AN, Turetskaya RL, Kuprash DV, Nedospasov SA. Immunodetection of murine lymphotoxins in eukaryotic cells. Russian J Immunol 2000; 5:259-266.
33.    Eskdale J, Turetskaya RL, Armstrong C, Kuprash DV, Nedospasov SA, Gallagher G. A polymorphic microsatellite marker in the human p55 TNF receptor, CD120a. Genes Immun 2000; 1: 228-230.
34.    Boitchenko VE, Alimzhanov MB, Turetskaya RL, Ruhlmann A, Nordheim A, Kuprash DV, Nedospasov SA. [Comparative Characterization of Lymphotoxin Transcripts from Human B- and T-Cell Lines, Peripheral Lymphocytes, and Normal Tissues]. Mol Biol (Mosk) 2001; 35: 115-121.
35.    Radko BV, Boitchenko VE, Nedospasov SA, Korobko VG. Characterization of the genes encoding variable light and heavy chains of the high-affinity monoclonal antibody against human tumor necrosis factor. Russian Journal of Immunology, 2002, 7(4): 371-374.

 

5. Other research in molecular biology:

36. Kashkin KN, Khlgatian SV, Gurova OV, Kuprash DV, Nedospasov SA. New mutations in the human p53 gene – a regulator of the cell cycle and carcinogenesis. Biochemistry (Mosc). 2007, 72(3):282-92

 

6. Reviews:

37.    Nedospasov SA, Grivennikov SI, Kuprash DV. Physiologic roles of members of the TNF and TNF receptor families as revealed by knockout models. In: "Contemporary immunology: Cytokine Knockouts" 2nd edition, Giamila Fantuzzi, Ed., 2003, Humana Press, Inc., Totowa, NJ, 439-460.
38.    Nedospasov SA, Kuprash DV. [Cytokines, their receptors and intracellular signal transduction]. In: Cancerogenesis [Russian], DG Zaridze ed., 2004, Meditsina, Moscow, 158-168.
39.    Nedospasov SA, Lavrik IN. [Mechanisms of activation of programmed cell death via death receptors]. In: Cancerogenesis [Russian], DG Zaridze ed., 2004, Meditsina, Moscow, 168-179.

40. Nedospasov SA, Kuprash DV. Oncoimmunology: some fundamental problems of cancer immunotherapy. Mol Biol (Mosk). 2007 Mar-Apr; 41(2): 355-68.

41. Shebzukhov IuV, Belousov PV, Khlgatian SV, Sazykin AIu, Kuprash DV, Nedospasov SA. Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens. Mol Gen Mikrobiol Virusol. 2007;(2):3-6.

42. Belousov PV, Shezbukhov IuV, Nedospasov SA, Kuprash DV.Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders. Mol Gen Mikrobiol Virusol. 2007;(2):6-13.

 

 


Last update October 17, 2007 by Dmitry Kuprash and Maria Goncharskaya